Pfizer, Black Box, Laxmi India Finance Share Price React Post Q1 Results

Market Performance

On August 14, markets witnessed notable movements in Pfizer, Black Box, and Laxmi India Finance share prices as investors reacted to the companies’ Q1 FY26 financial results. While Pfizer saw a sharp gain, Black Box hit a lower circuit, and Laxmi India Finance faced mild selling pressure.

Pfizer: Strong Q1 Performance Lifts Shares

In early trade, Pfizer shares rose 5.5% following the company’s announcement of a 27% year-on-year increase in net profit for the quarter closing on June 30, 2025.

Financial Highlights:

• Net Profit: ₹192 crore (vs ₹151 crore in Q1 FY25)
• Revenue: ₹604 crore, up 7% YoY
• EBITDA: ₹210 crore, up 18% YoY
• EBITDA Margin: 34.8% (vs 31.5% in Q1 FY25)

At 9:50 am, Pfizer share price was trading 5% higher at ₹5,359 apiece.

Black Box: Lower Circuit After Sequential Profit Decline

Black Box shares hit the 5% lower circuit after reporting a 22% sequential drop in net profit to ₹47 crore in Q1 FY26. On a yearly basis, the profit was up 28%.

Key Numbers:

• Revenue: ₹1,387 crore, down 3% YoY
• EBITDA: ₹116 crore, up 1% YoY
• EBITDA Margin: 8.4% (improved by 30 basis points YoY)

The company attributed the decline to client-driven delays in equipment procurement due to the prevailing tariff environment, impacting service execution and revenue recognition. At 9:58 am, Black Box share price was 3.7% lower at ₹477 apiece.

Laxmi India Finance: Post-Listing Pressure Continues

Newly-listed Laxmi India Finance saw its shares decline nearly 3% after reporting a 33% sequential drop in net profit to ₹10 crore for Q1 FY26. However, the profit was 43% higher YoY.

Financial Snapshot:

• Revenue: ₹70 crore, up 41% YoY (₹51 crore in Q1 FY25)
• Net Profit: ₹10 crore, down 33% QoQ, up 43% YoY

At 10:08 am, Laxmi India Finance share price was trading 2.6% lower at ₹145.7 apiece.

Summary

The Q1 FY26 results triggered contrasting movements in Pfizer, Black Box, and Laxmi India Finance share prices on August 14. While Pfizer gained on strong revenue and profit growth, Black Box faced selling pressure due to sequential decline in earnings, and Laxmi India Finance continued to correct post-listing despite strong YoY revenue growth.